Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity

S Y Lee1, S Y Lee, G Kandala

  • 1Howard Hughes Medical Institute, Rockefeller University, New York, NY 10021, USA.

Proceedings of the National Academy of Sciences of the United States of America
|September 3, 1996
PubMed
Summary

CD30 signaling activates NF-kappa B and HIV transcription via TRAF2. Researchers identified two TRAF binding sites on CD30, including a specific TRAF-C binding site.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum to 'Leukemia inhibitory factor (LIF) potentiates antinociception activity and inhibits tolerance induction of opioids' [Br J Anaesth 2016; 117: 512-520].

British journal of anaesthesia·2018
Same author

Leukemia inhibitory factor (LIF) potentiates antinociception activity and inhibits tolerance induction of opioids.

British journal of anaesthesia·2017
Same author

Comparison of antimicrobial resistance patterns between clinical and sewage isolates in a regional hospital in Taiwan.

Letters in applied microbiology·2009
Same author

Association of serum protein levels with egg productivity in Taiwan red-feathered country chickens.

Animal reproduction science·2006
Same author

Survival of leukemic B cells promoted by engagement of the antigen receptor.

Blood·2001
Same author

c-Rel is required for the protection of B cells from antigen receptor-mediated, but not Fas-mediated, apoptosis.

Journal of immunology (Baltimore, Md. : 1950)·2001

Area of Science:

  • Immunology
  • Molecular Biology
  • Virology

Background:

  • CD30 is a TNF receptor superfamily member expressed on lymphocytes and in Hodgkin's lymphoma.
  • CD30 signaling triggers cellular responses like proliferation, differentiation, and apoptosis.
  • TNF receptor-associated factors (TRAFs) mediate signals from related receptors like TNF-R2 and CD40.

Purpose of the Study:

  • To investigate the role of TRAF2 in CD30-induced NF-kappa B activation.
  • To determine if TRAF2-mediated signaling contributes to CD30-induced HIV transcription.
  • To map the interaction sites between CD30 and TRAFs.

Main Methods:

  • Site-directed mutagenesis of the CD30 cytoplasmic tail.
  • Assays to measure NF-kappa B activation.

Related Experiment Videos

  • Analysis of HIV transcription in response to CD30 cross-linking.

    • Main Results:

    • TRAF2 is crucial for CD30-induced NF-kappa B activation.
    • TRAF2-mediated NF-kappa B activation contributes to CD30-induced HIV transcription.
    • Two distinct TRAF binding sites were identified on the CD30 cytoplasmic tail.
    • A specific 5-7 amino acid stretch was identified as the TRAF-C binding site.

    Conclusions:

    • TRAF2 is a key mediator of CD30 signaling pathways.
    • CD30 signaling can influence viral transcription through TRAF-mediated pathways.
    • Detailed mapping of CD30-TRAF interactions provides insights into receptor signaling mechanisms.